Up-converted nano-gasholder with precise nitric oxide release remodels immunosuppressive microenvironment and potentiates tumor immunotherapy
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Immune cells in cancer · Cancer, Stress, Anesthesia, and Immune Response
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (52)
Show source-provided references
1. Cancer immunotherapy: harnessing the immune system to battle cancer10.1172/JCI83871 ↗
2. Immunotherapy: cancer immunotherapy and the value of cure10.1038/nrclinonc.2018.27 ↗
3. Immune checkpoint blockade therapy10.1016/j.jaci.2018.02.042 ↗
4. Cancer immunotherapy: the beginning of the end of cancer?10.1186/s12916-016-0623-5 ↗
5. Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma10.1056/NEJMoa1305133 ↗
6. Improved survival with lpilimumab in patients with metastatic melanoma10.1056/NEJMoa1003466 ↗
7. The future of cancer immunotherapy: microenvironment-targeting combinations10.1038/s41422-020-0337-2 ↗
8. Toward biomaterials for enhancing immune checkpoint blockade therapy10.1002/adfm.201802540 ↗
9. Immune checkpoint signaling and cancer immunotherapy10.1038/s41422-020-0343-4 ↗
10. NIR-light triggered dual-cascade targeting core-shell nanoparticles enhanced photodynamic therapy and immunotherapy10.1016/j.nantod.2021.101288 ↗
11. Immunogenic cell death amplified by co-localized adjuvant delivery for cancer immunotherapy10.1021/acs.nanolett.7b03218 ↗
12. On-demand autophagy cascade amplification nanoparticles precisely enhanced oxaliplatin-induced cancer immunotherapy
13. Oxaliplatin induces immunogenic cell death in hepatocellular carcinoma cells and synergizes with immune checkpoint blockade therapy10.1007/s13402-020-00552-2 ↗
14. Double enhancement of immunogenic cell death and antigen presentation for cancer immunotherapy10.1016/j.nantod.2021.101225 ↗
15. Immunogenic cell death and DAMPs in cancer therapy10.1038/nrc3380 ↗
16. Targeting immunogenic cell death in cancer10.1002/1878-0261.12851 ↗
17. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 201810.1038/s41418-017-0012-4 ↗
18. Immunogenic cell death in cancer therapy10.1146/annurev-immunol-032712-100008 ↗
19. Immunogenic cell death in cancer and infectious disease10.1038/nri.2016.107 ↗
20. Nanocage-therapeutics prevailing phagocytosis and immunogenic cell death awakens immunity against cancer
21. Effects of immune cells and cytokines on inflammation and immunosuppression in the tumor microenvironment10.1016/j.intimp.2020.106939 ↗
22. Targeted therapy and immunosuppression in the tumor microenvironment10.1016/j.trecan.2016.11.009 ↗
23. Innate and adaptive immune cells in the tumor microenvironment10.1038/ni.2703 ↗
24. Immune suppressive mechanisms in the tumor microenvironment10.1016/j.coi.2015.10.009 ↗
25. Carry-on nitric-oxide luggage for enhanced chemotherapeutic efficacy10.1021/acs.nanolett.0c01532 ↗
26. Photoresponsive vesicles enabling sequential release of nitric oxide (NO) and gentamicin for efficient biofilm radication10.1002/marc.202000759 ↗
27. Nitric oxide therapy for diabetic wound healing10.1002/adhm.201801210 ↗
28. Optically-controlled bacterial metabolite for cancer therapy10.1038/s41467-018-03233-9 ↗
29. Surface charge switchable supramolecular nanocarriers for nitric oxide synergistic photodynamic eradication of biofilms10.1021/acsnano.9b05493 ↗
30. Light-triggered nitric oxide (NO) release from photoresponsive polymersomes for corneal wound healing10.1039/C9SC04039K ↗
31. Non-thermal plasma induces immunogenic cell death in vivo in murine CT26 colorectal tumors10.1080/2162402X.2018.1484978 ↗
32. Non-thermal plasma as a unique delivery system of short-lived reactive oxygen and nitrogen species for immunogenic cell death in melanoma cells10.1002/advs.201802062 ↗
33. Fighting immune cold and reprogramming immunosuppressive tumor microenvironment with red blood cell membrane-camouflaged nanobullets10.1021/acsnano.0c07721 ↗
34. Nitric oxide-mediated enhancement and reversal of resistance of anticancer therapies10.3390/antiox8090407 ↗
35. Gas-generating nanoplatforms: material chemistry, multifunctionality, and gas therapy10.1002/adma.201801964 ↗
36. Progress and promise of nitric oxide-releasing platforms10.1002/advs.201701043 ↗
37. Nitric oxide-driven nanomotor for deep tissue penetration and multidrug resistance reversal in cancer therapy10.1002/advs.202002525 ↗
38. Delivery of nitric oxide with a nanocarrier promotes tumour vessel normalization and potentiates anti-cancer therapies10.1038/s41565-019-0570-3 ↗
39. Enhanced drug delivery by nanoscale integration of a nitric oxide donor to induce tumor collagen depletion10.1021/acs.nanolett.8b04236 ↗
40. Inherently nitric oxide containing polymersomes remotely regulated by NIR for improving multi-modal therapy on drug resistant cancer10.1016/j.biomaterials.2021.121118 ↗
41. Stimuli-responsive NO release for on-demand gas-sensitized synergistic cancer therapy10.1002/anie.201800594 ↗
42. Advanced nitric oxide donors: chemical structure of NO drugs, NO nanomedicines and biomedical applications10.1039/D0NR07484E ↗
43. Red-light-mediated photoredox catalysis enables self-reporting nitric oxide release for efficient antibacterial treatment10.1002/anie.202107155 ↗
44. NIR light-responsive nanocarriers for controlled release10.1016/j.jphotochemrev.2021.100420 ↗
45. Remote light-responsive nanocarriers for controlled drug delivery: advances and perspectives10.1002/smll.201903060 ↗
46. Light-switchable yolk-mesoporous shell UCNPs@MgSiO3 for nitric oxide-evoked multidrug resistance reversal in cancer therapy10.1021/acsami.0c06102 ↗
47. Near-infrared light-triggered NO release for spinal cord injury repair10.1126/sciadv.abc3513 ↗
48. Functional biodegradable nitric oxide donor-containing polycarbonate-based micelles for reduction-triggered drug release and overcoming multidrug resistance10.1021/acsmacrolett.9b00758 ↗
49. Theoretical study on stabilization mechanisms of nitrate esters using aromatic amines as stabilizers10.1016/j.jhazmat.2017.06.025 ↗
50. Photolysis of nitrate esters-II. Solution photolysis of aralkyl nitrate esters: kinetics, esr spectra, and photoproducts10.1111/j.1751-1097.1965.tb07909.x ↗
51. The role of efflfluent nitrate in trace organic chemical oxidation during UV disinfection10.1016/j.watres.2012.06.052 ↗
52. Tumor-intrinsic determinants of immunogenic cell death modalities10.1080/2162402X.2021.1893466 ↗